
Abdel A. Mohamed
Examiner (ID: 6501)
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1653, 1806, 1811, 1654, 1815, 1611, 1803 |
| Total Applications | 1048 |
| Issued Applications | 680 |
| Pending Applications | 109 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7629734
[patent_doc_number] => 06818622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-16
[patent_title] => 'Selective MMP inhibitors having reduced side-effects'
[patent_app_type] => B2
[patent_app_number] => 09/862035
[patent_app_country] => US
[patent_app_date] => 2001-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3389
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/818/06818622.pdf
[firstpage_image] =>[orig_patent_app_number] => 09862035
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/862035 | Selective MMP inhibitors having reduced side-effects | May 20, 2001 | Issued |
Array
(
[id] => 1175736
[patent_doc_number] => 06747001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-08
[patent_title] => 'Bioactive peptides, uses thereof and process for the production of same'
[patent_app_type] => B2
[patent_app_number] => 09/854968
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2869
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/747/06747001.pdf
[firstpage_image] =>[orig_patent_app_number] => 09854968
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/854968 | Bioactive peptides, uses thereof and process for the production of same | May 13, 2001 | Issued |
Array
(
[id] => 5922916
[patent_doc_number] => 20020115600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Inhibitors of memapsin 2 and use thereof'
[patent_app_type] => new
[patent_app_number] => 09/845226
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19721
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115600.pdf
[firstpage_image] =>[orig_patent_app_number] => 09845226
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/845226 | Inhibitors of memapsin 2 and use thereof | Apr 29, 2001 | Abandoned |
Array
(
[id] => 1034408
[patent_doc_number] => 06875617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-05
[patent_title] => 'Agent for protein precipitation, a method of protein precipitation, a method of protein assay using protein precipitation agent, and a kit for protein assay'
[patent_app_type] => utility
[patent_app_number] => 09/842838
[patent_app_country] => US
[patent_app_date] => 2001-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 11018
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875617.pdf
[firstpage_image] =>[orig_patent_app_number] => 09842838
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/842838 | Agent for protein precipitation, a method of protein precipitation, a method of protein assay using protein precipitation agent, and a kit for protein assay | Apr 26, 2001 | Issued |
Array
(
[id] => 1108280
[patent_doc_number] => 06809177
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-26
[patent_title] => 'Process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues'
[patent_app_type] => B1
[patent_app_number] => 09/673836
[patent_app_country] => US
[patent_app_date] => 2001-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1653
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/809/06809177.pdf
[firstpage_image] =>[orig_patent_app_number] => 09673836
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/673836 | Process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues | Mar 28, 2001 | Issued |
Array
(
[id] => 745022
[patent_doc_number] => 07026294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-11
[patent_title] => 'Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/275877
[patent_app_country] => US
[patent_app_date] => 2001-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6389
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/026/07026294.pdf
[firstpage_image] =>[orig_patent_app_number] => 10275877
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/275877 | Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes | Mar 20, 2001 | Issued |
Array
(
[id] => 5788288
[patent_doc_number] => 20020160937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Human vitreous and pharmaceutical compositions'
[patent_app_type] => new
[patent_app_number] => 09/801736
[patent_app_country] => US
[patent_app_date] => 2001-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1846
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160937.pdf
[firstpage_image] =>[orig_patent_app_number] => 09801736
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/801736 | Human vitreous and pharmaceutical compositions | Mar 8, 2001 | Abandoned |
Array
(
[id] => 6156710
[patent_doc_number] => 20020146409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Methods for stabilizing lyophilized blood proteins'
[patent_app_type] => new
[patent_app_number] => 09/772634
[patent_app_country] => US
[patent_app_date] => 2001-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3436
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146409.pdf
[firstpage_image] =>[orig_patent_app_number] => 09772634
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/772634 | Methods for stabilizing lyophilized blood proteins | Jan 29, 2001 | Abandoned |
| 09/772512 | Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof | Jan 28, 2001 | Abandoned |
Array
(
[id] => 6730668
[patent_doc_number] => 20030186858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Crystallisation of a GLP-1 analogue'
[patent_app_type] => new
[patent_app_number] => 09/769692
[patent_app_country] => US
[patent_app_date] => 2001-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11465
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186858.pdf
[firstpage_image] =>[orig_patent_app_number] => 09769692
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/769692 | Crystallization of a GLP-1 analogue | Jan 24, 2001 | Issued |
Array
(
[id] => 6016864
[patent_doc_number] => 20020103129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Small peptides having anti-angiogenic and endothelial cell inhibition activity'
[patent_app_type] => new
[patent_app_number] => 09/766412
[patent_app_country] => US
[patent_app_date] => 2001-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4386
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103129.pdf
[firstpage_image] =>[orig_patent_app_number] => 09766412
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/766412 | Small peptides having anti-angiogenic and endothelial cell inhibition activity | Jan 21, 2001 | Issued |
Array
(
[id] => 1102192
[patent_doc_number] => 06815533
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-09
[patent_title] => 'Cryogranulation of activated protein C'
[patent_app_type] => B1
[patent_app_number] => 09/744432
[patent_app_country] => US
[patent_app_date] => 2001-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3619
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/815/06815533.pdf
[firstpage_image] =>[orig_patent_app_number] => 09744432
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/744432 | Cryogranulation of activated protein C | Jan 21, 2001 | Issued |
Array
(
[id] => 6934834
[patent_doc_number] => 20010056178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-27
[patent_title] => 'Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them'
[patent_app_type] => new
[patent_app_number] => 09/767080
[patent_app_country] => US
[patent_app_date] => 2001-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18236
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20010056178.pdf
[firstpage_image] =>[orig_patent_app_number] => 09767080
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/767080 | Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them | Jan 21, 2001 | Issued |
Array
(
[id] => 472228
[patent_doc_number] => 07229789
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-06-12
[patent_title] => 'Methods and compositions for extracting proteins from cells'
[patent_app_type] => utility
[patent_app_number] => 09/766043
[patent_app_country] => US
[patent_app_date] => 2001-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4095
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/229/07229789.pdf
[firstpage_image] =>[orig_patent_app_number] => 09766043
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/766043 | Methods and compositions for extracting proteins from cells | Jan 18, 2001 | Issued |
Array
(
[id] => 1120395
[patent_doc_number] => 06797810
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-28
[patent_title] => 'Method for isolation and modification of proteins'
[patent_app_type] => B1
[patent_app_number] => 09/674034
[patent_app_country] => US
[patent_app_date] => 2001-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6809
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/797/06797810.pdf
[firstpage_image] =>[orig_patent_app_number] => 09674034
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/674034 | Method for isolation and modification of proteins | Jan 2, 2001 | Issued |
Array
(
[id] => 5860097
[patent_doc_number] => 20020123615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Quality improvement for animal whole blood protein products'
[patent_app_type] => new
[patent_app_number] => 09/753088
[patent_app_country] => US
[patent_app_date] => 2001-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1602
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20020123615.pdf
[firstpage_image] =>[orig_patent_app_number] => 09753088
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/753088 | Quality improvement for animal whole blood protein products | Jan 1, 2001 | Abandoned |
Array
(
[id] => 6472732
[patent_doc_number] => 20020151467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Methods and compositions for oral insulin delivery'
[patent_app_type] => new
[patent_app_number] => 09/746855
[patent_app_country] => US
[patent_app_date] => 2000-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8082
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151467.pdf
[firstpage_image] =>[orig_patent_app_number] => 09746855
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/746855 | Methods and compositions for oral insulin delivery | Dec 20, 2000 | Abandoned |
Array
(
[id] => 6878264
[patent_doc_number] => 20010002419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-05-31
[patent_title] => 'Chemical modification of proteins to improve biocompatibility and bioactivity'
[patent_app_type] => new-utility
[patent_app_number] => 09/742601
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6344
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20010002419.pdf
[firstpage_image] =>[orig_patent_app_number] => 09742601
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/742601 | Chemical modification of proteins to improve biocompatibility and bioactivity | Dec 18, 2000 | Issued |
Array
(
[id] => 1579314
[patent_doc_number] => 06448378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-09-10
[patent_title] => 'Compound delivery using rapidly dissolving collagen film'
[patent_app_type] => B2
[patent_app_number] => 09/735182
[patent_app_country] => US
[patent_app_date] => 2000-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2638
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/448/06448378.pdf
[firstpage_image] =>[orig_patent_app_number] => 09735182
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/735182 | Compound delivery using rapidly dissolving collagen film | Dec 11, 2000 | Issued |
| 09/646748 | METHOD FOR PROVIDING GLUTAMINE | Dec 10, 2000 | Abandoned |